Virpax Pharmaceuticals, Inc.·4

Apr 9, 5:03 PM ET

Mack Anthony P. 4

4 · Virpax Pharmaceuticals, Inc. · Filed Apr 9, 2021

Insider Transaction Report

Form 4
Period: 2021-04-07
Mack Anthony P.
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-07+50,00050,000 total
    Exercise: $4.62Exp: 2031-04-07Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The option vests in three equal annual installments commencing on April 7, 2022.

Documents

1 file
  • 4
    mack_fm4april72021.xmlPrimary